Terfenadine-beta-Cyclodextrin inclusion complex with antihistaminic activity enhancement. 2001

H G Choi, and B J Lee, and J H Han, and M K Lee, and K M Park, and C S Yong, and J D Rhee, and Y B Kim, and C K Kim
College of Pharmacy, Seoul National University, South Korea.

Terfenadine, an antihistaminic drug, has relatively low bioavailability after oral administration due to its limited solubility in water. To enhance the antihistaminic activity of terfenadine, the terfenadine-beta-cyclodextrin (1:2) inclusion complex was prepared by the neutralization method. The solubility and dissolution of the inclusion complex were carried out, and its antihistaminic activity was then evaluated and compared with terfenadine powder by the passive subcutaneous anaphylaxis method in rats. The formation constant of the inclusion complex was higher at lower pH, while its formation ratio was 1:2 irrespective of pH. For terfenadine, it improved the solubility 200 times and the dissolution rate 5 times. It gave a low histamine level at 30 min, followed by a sustained low level until 60 min, while terfenadine powder gave a low histamine level at 60 min, suggesting that it had faster and more effective antihistaminic activity than terfenadine powder in rats due to fast dissolution and absorption of terfenadine. It is concluded that this inclusion complex enhanced the antihistaminic activity of terfenadine following the enhanced solubility and dissolution of terfenadine.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D010323 Passive Cutaneous Anaphylaxis An evanescent cutaneous reaction occurring when antibody is injected into a local area on the skin and antigen is subsequently injected intravenously along with a dye. The dye makes the rapidly occurring capillary dilatation and increased vascular permeability readily visible by leakage into the reaction site. PCA is a sensitive reaction for detecting very small quantities of antibodies and is also a method for studying the mechanisms of immediate hypersensitivity. Anaphylaxis, Passive Cutaneous,PCA,Cutaneous Anaphylaxis, Passive
D011208 Powders Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. (From Dorland, 28th ed) Powder
D002152 Calorimetry, Differential Scanning Differential thermal analysis in which the sample compartment of the apparatus is a differential calorimeter, allowing an exact measure of the heat of transition independent of the specific heat, thermal conductivity, and other variables of the sample. Differential Thermal Analysis, Calorimetric,Calorimetric Differential Thermal Analysis,Differential Scanning Calorimetry,Scanning Calorimetry, Differential
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries
D003505 Cyclodextrins A homologous group of cyclic GLUCANS consisting of alpha-1,4 bound glucose units obtained by the action of cyclodextrin glucanotransferase on starch or similar substrates. The enzyme is produced by certain species of Bacillus. Cyclodextrins form inclusion complexes with a wide variety of substances. Cycloamylose,Cyclodextrin,Cyclodextrin Derivatives,Cyclomaltooligosaccharides,Derivatives, Cyclodextrin
D005079 Excipients Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc. Excipient,Stabilizing Agent,Stabilizing Agents,Suspending Agent,Suspending Agents,Agent, Stabilizing,Agent, Suspending,Agents, Stabilizing,Agents, Suspending
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines
D006636 Histamine Release The secretion of histamine from mast cell and basophil granules by exocytosis. This can be initiated by a number of factors, all of which involve binding of IgE, cross-linked by antigen, to the mast cell or basophil's Fc receptors. Once released, histamine binds to a number of different target cell receptors and exerts a wide variety of effects. Histamine Liberation,Histamine Liberations,Histamine Releases

Related Publications

H G Choi, and B J Lee, and J H Han, and M K Lee, and K M Park, and C S Yong, and J D Rhee, and Y B Kim, and C K Kim
September 2003, Die Pharmazie,
H G Choi, and B J Lee, and J H Han, and M K Lee, and K M Park, and C S Yong, and J D Rhee, and Y B Kim, and C K Kim
January 1979, Acta pharmaceutica Hungarica,
H G Choi, and B J Lee, and J H Han, and M K Lee, and K M Park, and C S Yong, and J D Rhee, and Y B Kim, and C K Kim
March 2004, Biopolymers,
H G Choi, and B J Lee, and J H Han, and M K Lee, and K M Park, and C S Yong, and J D Rhee, and Y B Kim, and C K Kim
September 2005, Journal of pharmaceutical and biomedical analysis,
H G Choi, and B J Lee, and J H Han, and M K Lee, and K M Park, and C S Yong, and J D Rhee, and Y B Kim, and C K Kim
April 2006, The journal of physical chemistry. B,
H G Choi, and B J Lee, and J H Han, and M K Lee, and K M Park, and C S Yong, and J D Rhee, and Y B Kim, and C K Kim
November 2004, Die Pharmazie,
H G Choi, and B J Lee, and J H Han, and M K Lee, and K M Park, and C S Yong, and J D Rhee, and Y B Kim, and C K Kim
May 1992, Die Pharmazie,
H G Choi, and B J Lee, and J H Han, and M K Lee, and K M Park, and C S Yong, and J D Rhee, and Y B Kim, and C K Kim
January 2004, Journal of pharmaceutical sciences,
H G Choi, and B J Lee, and J H Han, and M K Lee, and K M Park, and C S Yong, and J D Rhee, and Y B Kim, and C K Kim
February 1979, Chemical & pharmaceutical bulletin,
H G Choi, and B J Lee, and J H Han, and M K Lee, and K M Park, and C S Yong, and J D Rhee, and Y B Kim, and C K Kim
March 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
Copied contents to your clipboard!